Literature DB >> 30019916

Need for a Judicious Use of Nonsteroidal Anti-inflammatory Drugs to Avoid Community-Acquired Acute Kidney Injury.

Amy Barton Pai1, Holly Divine2, Macary Marciniak3, Anthony Morreale4, Joseph J Saseen5, Kenneth Say6, Alissa R Segal7,8, Jenna M Norton9, Andrew S Narva9.   

Abstract

Millions of Americans use over-the-counter analgesics on a daily basis, and nearly 100 million nonsteroidal anti-inflammatory drug (NSAID) prescriptions are filled per year. In high-risk patients, these medications can disrupt kidney hemodynamics and precipitate community-acquired acute kidney injury (CA-AKI). The risk of NSAID-associated CA-AKI increases 3- to 5-fold in patients taking renin-angiotensin system inhibitors and diuretics concurrently. CA-AKI increases the risk of developing chronic kidney disease (CKD) or accelerating progression of pre-existing CKD. Importantly, many cases of NSAID-induced CA-AKI may be avoided by identifying high-risk patients and providing patient and provider education on when to avoid these medications and minimize risk.

Entities:  

Keywords:  NSAIDs; acute kidney injury; education; public policy

Year:  2018        PMID: 30019916     DOI: 10.1177/1060028018789174

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

1.  Association between NSAID Exposure and Kidney Function Decline in Primary Care Patients.

Authors:  Amy Barton Pai; Joseph A Vassalotti; Chester H Fox; Jennifer K Carroll; Gerald E Pulver; L Miriam Dickinson; Wilson D Pace
Journal:  Kidney360       Date:  2020-04-07

2.  Can NSAIDs be used safely for analgesia in patients with CKD?: PRO.

Authors:  Erin F Barreto; Molly A Feely
Journal:  Kidney360       Date:  2020-11

3.  Assessment of literacy and numeracy skills related to non-steroidal anti-inflammatory drug labels.

Authors:  Soo Min Jang; Ruixin Jiang; Darren Grabe; Amy Barton Pai
Journal:  SAGE Open Med       Date:  2019-03-07

4.  Frequency of nonaspirin NSAID-relevant coexisting medical conditions in the primary-care setting: a retrospective database review.

Authors:  Leslie Bloom; Kathleen E Boyle; Andrew E Myers; Claire Blacketer; Rachel Weinstein
Journal:  Ther Clin Risk Manag       Date:  2019-04-24       Impact factor: 2.423

5.  Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2.

Authors:  Xiao-Ying Liao; Qiang-Qiang Deng; Li Han; Zhi-Tao Wu; Zhao-Liang Peng; Yuan Xie; Guang-Ji Wang; Ji-Ye Aa; Guo-Yu Pan
Journal:  Acta Pharmacol Sin       Date:  2019-07-24       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.